Fexofenadine Hydrochloride Patent Expiration
Fexofenadine Hydrochloride is used for treating respiratory allergies, hives (urticaria), and their associated symptoms in adults and children. It was first introduced by Chattem Inc Dba Sanofi Consumer Healthcare
Fexofenadine Hydrochloride Patents
Given below is the list of patents protecting Fexofenadine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Children's Allegra Allergy | US8933097 | Fexofenadine suspension formulation | Aug 02, 2030 | Chattem Sanofi |
| Children's Allegra Hives | US8933097 | Fexofenadine suspension formulation | Aug 02, 2030 | Chattem Sanofi |
| Children's Allegra Allergy | US6723348 | Orodispersible tablets containing fexofenadine |
Nov 26, 2021
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US6723348 | Orodispersible tablets containing fexofenadine |
Nov 26, 2021
(Expired) | Chattem Sanofi |
| Allegra |
US6037353 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Sep 14, 2017
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US6037353 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Sep 14, 2017
(Expired) | Chattem Sanofi |
| Allegra Hives |
US6037353 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Sep 14, 2017
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US6037353 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Sep 14, 2017
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US6037353 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Sep 14, 2017
(Expired) | Chattem Sanofi |
| Allegra | US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
Mar 14, 2017
(Expired) | Chattem Sanofi |
| Allegra Allergy | US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
Mar 14, 2017
(Expired) | Chattem Sanofi |
| Allegra Hives | US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
Mar 14, 2017
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
Mar 14, 2017
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
Mar 14, 2017
(Expired) | Chattem Sanofi |
| Allegra |
US5738872 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra |
US5855912 (Pediatric) | Pharmaceutical compositions for piperidinalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra |
US5932247 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra |
US6113942 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US5855912 (Pediatric) | Pharmaceutical compositions for piperidinalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US5932247 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US6113942 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Hives |
US5855912 (Pediatric) | Pharmaceutical compositions for piperidinalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Hives |
US5932247 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Hives |
US6113942 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US5855912 (Pediatric) | Pharmaceutical compositions for piperidinalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US5932247 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US6113942 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US5855912 (Pediatric) | Pharmaceutical compositions for piperidinalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US5932247 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US6113942 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
| Allegra | US5738872 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra | US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra | US5932247 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra | US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Allergy | US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Allergy | US5932247 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Allergy | US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Hives | US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Hives | US5932247 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra Hives | US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US5738872 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US5932247 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US5738872 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US5932247 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
| Allegra |
US7135571 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Allegra |
US7138524 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US7135571 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US7138524 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Hives |
US7135571 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Hives |
US7138524 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US7135571 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US7138524 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US7135571 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US7138524 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
| Allegra |
US5578610 (Pediatric) | Piperidine derivatives |
May 26, 2014
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US5578610 (Pediatric) | Piperidine derivatives |
May 26, 2014
(Expired) | Chattem Sanofi |
| Allegra Hives |
US5578610 (Pediatric) | Piperidine derivatives |
May 26, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US5578610 (Pediatric) | Piperidine derivatives |
May 26, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US5578610 (Pediatric) | Piperidine derivatives |
May 26, 2014
(Expired) | Chattem Sanofi |
| Allegra | US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Allegra | US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Allergy | US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Allergy | US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Hives | US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Allegra Hives | US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
| Allegra | US5578610 | Piperidine derivatives |
Nov 26, 2013
(Expired) | Chattem Sanofi |
| Allegra Allergy | US5578610 | Piperidine derivatives |
Nov 26, 2013
(Expired) | Chattem Sanofi |
| Allegra Hives | US5578610 | Piperidine derivatives |
Nov 26, 2013
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy | US5578610 | Piperidine derivatives |
Nov 26, 2013
(Expired) | Chattem Sanofi |
| Children's Allegra Hives | US5578610 | Piperidine derivatives |
Nov 26, 2013
(Expired) | Chattem Sanofi |
| Allegra |
US6187791 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Allegra |
US6399632 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US6187791 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Allegra Allergy |
US6399632 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Allegra Hives |
US6187791 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Allegra Hives |
US6399632 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US6187791 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Children's Allegra Allergy |
US6399632 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US6187791 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
| Children's Allegra Hives |
US6399632 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
Fexofenadine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List